Original Source(s)
Related Content
Invasive NSTEMI Strategy Shows No Benefit in Frail Patients
Frailty severity may identify older patients least likely to benefit—and potentially at higher risk—with invasive management.
May 6, 2026
-
4 min
New Study Identifies Hidden Aggressive and Potentially Targetable Neuroendocrine-Like Subtype of Lung Cancer
A new study from researchers at Fox Chase Cancer Center and collaborators across multiple institutions has identified a hidden subset of lung cancers that behave more like aggressive neuroendocrine tumors than traditional non-small cell lung cancer (NSCLC).
Liquid Biopsy Supports Precision Oncology
Experts highlight clinical value, workflow integration, and real-world impact in lung and breast cancer diagnostics
May 22, 2026
-
8 min